Neogene Therapeutics, an Amsterdam-based biotech startup today announced it has raised $110 million in a Series A financing to develop a new class of fully personalized neo-antigen T cell therapies to treat cancer. The round was co-led by EcoR1 Capital, Jeito Capital, […]